Urology
Volume 75, Issue 3 , Pages 526-532.e18 , March 2010

Economic Costs of Overactive Bladder in the United States

  • Michael L. Ganz

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, Massachusetts
    • Corresponding Author InformationReprint requests: Michael L. Ganz, M.S., Ph.D., Abt Bio-Pharma Solutions, Inc, 181 Spring St, Lexington, MA 02421
    • ,
  • Amy M. Smalarz

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, Massachusetts
    • ,
  • Tracey L. Krupski

      Affiliations

    • Department of Urology, University of Virginia, Charlottesville, Virginia
    • ,
  • Jennifer T. Anger

      Affiliations

    • David Geffen School of Medicine, University of California, Los Angeles, California
    • ,
  • Jim C. Hu

      Affiliations

    • Brigham and Women's Hospital, Boston, Massachusetts
    • ,
  • Kim U. Wittrup-Jensen

      Affiliations

    • Bayer Schering Pharma, Berlin, Germany
    • ,
  • Chris L. Pashos

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, Massachusetts

Received 5 May 2009 ,Accepted 26 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(09)02311-5

doi: 10.1016/j.urology.2009.06.096

Urology
Volume 75, Issue 3 , Pages 526-532.e18 , March 2010

Article Tools

* Image Usage & Resolution